Finance

Lists
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$1.58
+1.94%
(+0.030) 1D
$1.57
-0.61% (-0.0097)
Pre-market
Closed: Aug 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALDX...
Open
$1.59
High
$1.60
Low
$1.54
Mkt. cap
95.32M
Avg. vol.
1.12M
Volume
254.00
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.38
Beta
1.21
Shares outstanding
60.33M
No. of employees
6
Open
$1.59
High
$1.60
Low
$1.54
Mkt. cap
95.32M
Avg. vol.
1.12M
Volume
254.00
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.38
Beta
1.21
Shares outstanding
60.33M
No. of employees
6
News stories
From web sources and news partners
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees6
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com
Analyst ratings
Based on 1 analyst giving stock ratings to ALDX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ALDX in the last 3 months
Highest
Current $1.58
$2.00 (+26.58%)
Average
$2.00 (+26.58%)
Lowest
$2.00 (+26.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Hold
Reiterated
$2.00
+26.6%
08/17/2026
Thomas Shrader
BTIG
Buy
Maintained
$9.00
+469.6%
03/17/2026
Clara Dong
Jefferies
Buy
Maintained
$7.00
+343%
10/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.43M
4.30M
2.41M
3.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.57M
2.36M
1.14M
2.37M
Operating expense
8.00M
6.67M
3.55M
5.85M
Total operating expenses
8.00M
6.67M
3.55M
5.85M
Operating income
-8.00M
-6.67M
-3.55M
-5.85M
Other non operating income
-
-
-
-
EBT including unusual items
-7.69M
-6.46M
-3.45M
-5.45M
EBT excluding unusual items
-7.69M
-6.46M
-3.45M
-5.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.69M
-6.46M
-3.45M
-5.45M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.10
-0.06
-0.09
Interest and investment income
788.69K
681.64K
562.98K
400.26K
Interest expense
-475.90K
-475.26K
-468.68K
-23.00
Net interest expenses
312.79K
206.38K
94.30K
400.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.94M
-6.60M
-3.48M
-5.78M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps